论文部分内容阅读
目的:观察生长抑素用于肠梗阻非手术治疗的临床疗效。方法:随机选取我院2013年1月至2016年1月82例肠梗阻患者进行治疗,41例患者给予常规治疗的患者(即为对照组),41例患者在常规治疗基础上给予生长抑素治疗(即为实验组),比较两组患者临床治疗效果。结果:实验组有39例患者病情好转,对照组有34例患者病情好转,实验组患者腹痛消失时间、肛肠排气时间以及住院时间均明显少于对照组,两组数据具有统计学意义(P<0.05)。结论:对于肠梗阻非手术治疗患者在常规药物治疗的基础上给予生长抑素治疗,能有效促进患者肠蠕动功能的恢复。
Objective: To observe the clinical efficacy of somatostatin for non-surgical treatment of intestinal obstruction. Methods: A total of 82 patients with intestinal obstruction were selected from January 2013 to January 2016 in our hospital. 41 patients were treated with conventional therapy (ie, control group). 41 patients were given somatostatin Treatment (that is, experimental group), the clinical efficacy of two groups were compared. Results: Thirty-nine patients in the experimental group improved in condition, 34 patients in the control group got better, and the disappearance of abdominal pain, anorectal discharge time and hospital stay in the experimental group were significantly less than those in the control group (P <0.05). CONCLUSIONS: Non-surgical treatment of intestinal obstruction in patients with conventional drug therapy based on the somatostatin treatment, can effectively promote the recovery of patients with peristalsis.